Health

Results: 6685-6696 of 8694

Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®

SmartCella strengthens team with Dr Ricardo Baptista as CTO

GlobeNewswire associated0

Fujifilm Healthcare Europe launches lifelike ESD training simulator EndoGel

PR Newswire associated0

Living Well Digitally: Global Initiative Launched by NUS Centre for Trusted Internet and Community and Powered by DQ

Denis Johnson joins Kindeva Drug Delivery as Chief Operating Officer, leading Kindeva’s state-of-the-art manufacturing, research, and development facilities located across the U.S. and U.K. (Photo: Business Wire)

Denis Johnson Joins Kindeva Drug Delivery as Chief Operating Officer to Lead Global Operations

PR Newswire associated0

Cognivia Secures Strategic 15.5M€ Funding to Empower Drug Development with AI-ML Solutions

Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain

TriLink BioTechnologies® Cuts Ribbon on New San Diego Facility for Late Phase mRNA Drug Substance Production (Photo: TriLink BioTechnologies®)

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024

Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology

PR Newswire associated0

European Wellness Leads Pioneering Down Syndrome Research at Heidelberg University

Learn more about the economic benefits of investing in adult immunisation programmes in a new study by the Office of Health Economics (OHE). Graphic: OHE

The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report